Fourteen patients with primary bronchogenic carcinoma, including 6 stage IIIA patients and 7 IIIB disease patients, underwent a pulmonary resection following cisplatin-based chemotherapy concurrent with 40 Gy of irradiation. The operations included 10 lobectomies, a bilobectomy, 2 pneumonectomies and a sleeve lobectomy. Dissection of the branches of the pulmonary artery was difficult, and an angioplastic procedure was employed in 2 patients. The average operating time was 306 minutes, and average blood loss was 338g. All patients were managed routinely, without any special measures. No major postoperative complication occurred, and patients were discharged from 11 to 35 days following surgery. Operative mortality rate was 0%. The median sur...
Objective: Non-small cell lung cancer (NSCLC) less than 2 cm from the carina or invading the tracheo...
ObjectiveOptimal management of stage IIIA-N2 non–small cell lung cancer remains controversial. The s...
BackgroundIn clinical stage IIIA non–small cell lung cancer, the role of surgical resection, particu...
Fourteen patients with primary bronchogenic carcinoma, including 6 stage IIIA patients and 7 IIIB di...
Background: Although the concept of induction therapy followed by surgical resection for locally adv...
AbstractObjectives: Patients receiving induction therapy may have increased risk of morbidity and mo...
AbstractObjective: The aim of this study was to ascertain the safety and efficacy of bronchial sleev...
ObjectiveUse and operative results of neoadjuvant therapy before major elective resection for primar...
OBJECTIVES: The effect of induction chemoradiotherapy (CRT) on bronchial anastomoses remains uncerta...
BACKGROUND: Induction chemotherapy before surgical resection increases survival compared with surgic...
Background : Induction chemotherapy before surgical resection increases survival compared with surgi...
Background and objective Because radical resection for lung cancer invading the initial borderline o...
AbstractObjective: The purpose of this study was to evaluate postchemoradiotherapy surgery in stage ...
Objectives: The purpose of this study was to evaluate the risk of lung cancer surgery following indu...
Seventy-one patients with primary bronchogenic carcinoma Underwent bronchoplastic procedures (48 sle...
Objective: Non-small cell lung cancer (NSCLC) less than 2 cm from the carina or invading the tracheo...
ObjectiveOptimal management of stage IIIA-N2 non–small cell lung cancer remains controversial. The s...
BackgroundIn clinical stage IIIA non–small cell lung cancer, the role of surgical resection, particu...
Fourteen patients with primary bronchogenic carcinoma, including 6 stage IIIA patients and 7 IIIB di...
Background: Although the concept of induction therapy followed by surgical resection for locally adv...
AbstractObjectives: Patients receiving induction therapy may have increased risk of morbidity and mo...
AbstractObjective: The aim of this study was to ascertain the safety and efficacy of bronchial sleev...
ObjectiveUse and operative results of neoadjuvant therapy before major elective resection for primar...
OBJECTIVES: The effect of induction chemoradiotherapy (CRT) on bronchial anastomoses remains uncerta...
BACKGROUND: Induction chemotherapy before surgical resection increases survival compared with surgic...
Background : Induction chemotherapy before surgical resection increases survival compared with surgi...
Background and objective Because radical resection for lung cancer invading the initial borderline o...
AbstractObjective: The purpose of this study was to evaluate postchemoradiotherapy surgery in stage ...
Objectives: The purpose of this study was to evaluate the risk of lung cancer surgery following indu...
Seventy-one patients with primary bronchogenic carcinoma Underwent bronchoplastic procedures (48 sle...
Objective: Non-small cell lung cancer (NSCLC) less than 2 cm from the carina or invading the tracheo...
ObjectiveOptimal management of stage IIIA-N2 non–small cell lung cancer remains controversial. The s...
BackgroundIn clinical stage IIIA non–small cell lung cancer, the role of surgical resection, particu...